TCM
RPRX icon

Teza Capital Management’s Royalty Pharma RPRX Stock Holding History

Teza Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,576
Closed -$230K – 736
2024
Q1 		$230K Buy
+7,576
New +$223K 0.03% 488
2023
Q4 		– Sell
-7,995
Closed -$217K – 729
2023
Q3 		$217K Sell
7,995
-152
-2% -$4.51K 0.04% 509
2023
Q2 		$250K Buy
+8,147
New +$276K 0.04% 449
2023
Q1 		– Sell
-20,793
Closed -$822K – 681
2022
Q4 		$822K Buy
+20,793
New +$868K 0.16% 215
2021
Q3 		– Sell
-5,461
Closed -$224K – 556
2021
Q2 		$224K Buy
+5,461
New +$232K 0.04% 504

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return